Coleman and Slomovitz Continue the Discussion on Maintenance PARP Inhibition in Ovarian Cancer
Season 3, Episode 35, Sep 03, 2020, 06:45 PM
In our exclusive interview, Dr. Coleman and Dr. Slomovitz discussed the benefits and limitations of PARP inhibition in all-comers with newly diagnosed advanced ovarian cancer and pivotal PARP inhibitor trials in the frontline setting.